Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 2, 2026 | Five Danish startups enter BII’s Venture House 8 cohort with €1.3 million follow-on backing | BioInnovation Institute (BII), a Novo Nordisk Foundation Initiative, has provided an additional €1.3 million in follow-on funding to five portfolio startups – Synuca Therapeutics, Gefjon Pharma, MicroMiner, DARERL and Diasense – bringing th... |
| SynuCa Therapeutics | “Innovative disease modifying treatment for Parkinson's patients” |
Reviews 0
FAQ about Synuca Therapeutics
How much funding has Synuca Therapeutics raised?
Synuca Therapeutics has raised $584.75K in total across 1 funding round.
What has the press written about Synuca Therapeutics?
Parsers VC has collected 3 articles mentioning Synuca Therapeutics, among them “Five Danish startups enter BII’s Venture House 8 cohort with €1.3 million follow-on backing” (Mar 2, 2026) and “SynuCa Therapeutics”.
Is Synuca Therapeutics still active?
Yes, Synuca Therapeutics is active; its latest activity on Parsers VC dates from Mar 3, 2026.